Here’s Why ALS Drug Relyvrio Is Being Removed From Market—And What That Means For Patients

  • 📰 ForbesTech
  • ⏱ Reading Time:
  • 20 sec. here
  • 11 min. at publisher
  • 📊 Quality Score:
  • News: 42%
  • Publisher: 59%

Amylyx Pharmaceuticals News

Relyvrio,Als,Amyotrophic Lateral Sclerosis

I'm a Texas native covering the latest trends in tech, science and healthcare through explainer pieces on the breaking news team. Previously, I was a Forbes HBCU Scholar writing under the innovation and health and science teams.

Today’s Biden-Netanyahu Call Could Get Tense After WCK Airstrike—But Key Allies Want More Than Tough Talk

$1.2 Billion Powerball Jackpot Is Now The Biggest Of 2024—Here’s What The Winner Could Take Home After TaxesDrug manufacturer Amylyx Pharmaceuticals announced on Thursday plans to remove Relyvrio from the market after lackluster results from a phase III trial, leaving only two other ALS drugs on the market.The process to remove the drug from the market in both Canada and the U.S.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 318. in NG

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Controversial ALS Drug May Be Pulled from Market After Disappointing Trial ResultsFollowing disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. Amylyx Pharmaceuticals is considering voluntarily withdrawing the drug, Relyvrio/Albrioza, after it failed to help patients in a large follow-up study. The company has decided to pause promotion of the medication and will announce their plans for the drug in the next two months.
Source: MedicineNet - 🏆 575. / 51 Read more »

ALS drug will be pulled from US market after study showed patients didn't benefitTexas Monthly's bracket narrowed the list to a Final Four - and then a winner.
Source: wfaa - 🏆 543. / 51 Read more »

ALS drug will be pulled from US market after study showed patients didn't benefitHigh temperatures remain in the 80s.
Source: KENS5 - 🏆 608. / 51 Read more »